Intercalation and induction of strand breaks by adriamycin and daunomycin: A study with human genomic DNA

DNA and Cell Biology

Volumn 31, Issue 3, 2012, Pages 377-386

  Ghosh, Debjani ^a   Hossain, Maidul ^b   Saha, Chabita ^a   Dey, Subrata Kumar ^a   Kumar, Gopinatha Suresh ^b  

^a MAULANA ABUL KALAM AZAD UNIVERSITY OF TECHNOLOGY   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; DOXORUBICIN; GENOMIC DNA; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC ANTIBIOTIC; DNA;

ARTICLE; DNA STRAND BREAKAGE; DRUG BINDING; DRUG STRUCTURE; FLUOROMETRY; GEL ELECTROPHORESIS; GENOTOXICITY; HUMAN; HUMAN CELL; INTERCALATION COMPLEX; LYMPHOCYTE; MELTING POINT; PRIORITY JOURNAL; TEMPERATURE; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; DNA DENATURATION; DOUBLE STRANDED DNA BREAK; DRUG EFFECT; GENETICS; HUMAN GENOME;

ANTIBIOTICS, ANTINEOPLASTIC; CIRCULAR DICHROISM; DAUNORUBICIN; DNA; DNA BREAKS, DOUBLE-STRANDED; DOXORUBICIN; GENOME, HUMAN; HUMANS; MOLECULAR STRUCTURE; NUCLEIC ACID DENATURATION;

EID: 84858121890     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1299     Document Type: Article

References (42)

1. Ames, B.N. (1983). Dietary carcinogens and anticarcinogens. Science 221, 1256-1264.
2. Bachur, N.R., Gee, M.V., and Friedman, R.D. (1982). Nuclear catalysed antibiotic free radical formation. Cancer Res 42, 1078-1081. (Pubitemid 12141222)
3. Berlin, V., and Haseltine, W.A. (1981). Reduction of adriamycin to a semiquinine-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen. J Biol Chem 256, 4747-4756. (Pubitemid 11035330)
4. Boyum, A. (1974). Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens 4, 269-274.
5. Brown, J.M., and Wouters, B.G. (1999). Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 59, 1391-1399. (Pubitemid 29160097)
6. Chaires, J.B., Fox, K.R., Herrera, J.E., Britt, M., and Waring, M.J. (1987). Site and sequence specificity of the daunomycin-DNA interaction. Biochem 26, 8227-8236. (Pubitemid 18023067)
7. Coldwell, K.E., Cutts, S.M., Ognibene, T.J., Henderson, P.T., and Phillips, D.R. (2008). Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations. Nucleic Acids Res 36, e100.
8. Coldwell, K.E., Cutts, S.M., Ognibene, T.J., Henderson, P.T., and Phillips, D.R. (2010). Detection of adriamycin-DNA adducts by accelerator mass spectrometry. Methods Mol Biol 613, 103-118.
9. Collins, A.R., Dusinska, M., Gedik, C.M., and Stetina, R. (1996). Oxidative damage to DNA: Do we have a reliable biomarker? Environ Health Perspect 104, 465-469. (Pubitemid 26197677)
10. Collins, A.R., Duthie, S.J., and Dobson V.L. (1993). Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 14, 1733-1735. (Pubitemid 23290881)
11. Denny, W.A., Cain, B.F., Atwell, G.J., Hansch, C., Panthananickal, A., and Leo, A. (1982). Potential antitumor agents. 36. Quantitative relationship between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents. J Med Chem 25, 276-315. (Pubitemid 12158029)
12. DeVita, V.T., Hellman, S., Rosenberg, S.A., eds. (2001). Principles and Practice of Oncology, 6th ed. (Lippincott Williams and Wilkins, Philadelphia).
13. DiMarco, A., Gaetani, M., and Scarpinato, B. (1969). Adriamycin (NSC-123, 127): a new antibiotic with antitumor activity. Cancer Chemother Rept 53, 33-37.
14. Doroshow, J.H. (1986). Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. Proc Natl Acad Sci USA 83, 4514-4518. (Pubitemid 16057079)
15. Fink, S.I., Leo, A., Yamakawa, M., Hansch, C., and Quinn, F.R. (1980). The quantitative structure-selectivity relationship of anthracycline antitumor activity and cardiac toxicity. Farmaco Sci 35, 965-979. (Pubitemid 11166141)
16. Fornari, F.A., Randolph, J.K., Yalowich, J.C., Ritke, M.K., and Gewirtz, D.A. (1994). Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol 45, 649-656. (Pubitemid 24139191)
17. Frederick, C.A., Williams, L.D., Ugehtto, G., van del Marel, G.A., van Boom, J.H., Rich, A., and Wang, A.H.J. (1990). Structural comparison of anticancer drug-DNA complexes: adriyamycin and daunomycin. Biochem 29, 2538-2549. (Pubitemid 20100850)
18. Gewirtz, D.A. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57, 727-741. (Pubitemid 29094544)
19. Giri, P., and Kumar, G.S. (2008). Spectroscopic and calorimetric studies on the binding of the phototoxic and cytotoxic plant alkaloid sanguinarine with double helical poly(A). J Photochem Photobiol A Chem 194, 111-121.
20. Hartley, J.A. (2001). Alkylating agents. In Oxford Textbook of Oncology, 2nd edition. In Souhami, R.L., Tannock, I., Hohenberger, P., Horiot, J.C. eds. (Oxford University Press, Oxford) pp. 639-654.
21. Hartmann, A., Plappert, U., Poetter, F., and Suter, W. (2003). Comparative study with the alkaline Comet assay and the chromosome aberration test. Mut Res Genet Toxicol Environ Mutagen 536, 27-38. (Pubitemid 36411654)
22. Islam, M.M., and Kumar, G.S. (2009). RNA binding potential of protoberberine alkaloids: spectroscopic and calorimetric studies on the binding of berberine, palmatine, and coralyne to protonated RNA structure. DNA and Cell Biol 28, 1-13.
23. Kim, S.H., and Kim, J.H. (1972). Lethal effect of adriamycin on the division cycle of HeLa cells. Cancer Res 32, 323-325.
24. Liu, W.B., Zhou, J., Qu, Y., Lu, C.T., Xie, K.L., Sun, X.L., and Fei, Z. (2010). Neuroprotective effect of osthole on MPP+-induced cytotoxicity in PC12 cells via inhibition of mitochondrial dysfunction and ROS production. Neurochem Int 57, 206-215.
25. Lu, Y., Wang, G., Lv, J., Zhang, G., and Liu, Q. (2010). Study on the interaction of an anthracycline disaccharide with DNA by spectroscopic techniques and molecular modeling. J Fluoresc 21, 409-414.
26. Martinez, R., and Chacon-Garcia, L. (2005). The search of DNAintercalators as antitumoral drugs: what it worked and what did not work. Cur Med Chem 12, 127-151. (Pubitemid 40089830)
27. Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., and Gianni, L. (2004). Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 3, 185-229. (Pubitemid 38720829)
28. O'Brien, P.J. (1985). Free-radical-mediated DNA binding. Environ Health Persp 64, 219-232. (Pubitemid 16135792)
29. Pommier, Y. (1993). DNA topoisomerase I and II in cancer chemotherapy: update and perspectives. Cancer Chemother Pharmacol 32, 103-108. (Pubitemid 23131928)
30. Razek, A.A. (1971). A comparative study of daunomycin (D) and adriamycin (A). Proc Am Assoc Cancer Res 12, 20.
31. Robbie, M., and Wilkins, R.J. (1984). Identification of the specific sites of interaction between intercalating drugs and DNA. Chem Biol Interact 49, 189-207. (Pubitemid 14142586)
32. Ross, W.E., Glaubiger, D., and Kohn, K.W. (1979). Qualitative and quantitative aspects of intercalator-induced DNA strand breaks. Biochim Biophys Acta Nucl Acids Protein Synth 562, 41-50.
33. Sen, D., and Crothers, M.D. (1986). Influence of DNA-binding drugs on chromatin condensation. Biochem 25, 1503-1509. (Pubitemid 16013920)
34. Singh, N.P., McCoy, M.T., Tice, R.R., and Schneider, E.L. (1988). A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175, 184-191.
35. Sinha, B.K., and Gregory, J.L. (1981). Role of one-electron and two-electron reduction products of adriamycin and daunomycin in deoxoribonucleic acid binding. Biochem Pharmacol 30, 2626-2629. (Pubitemid 11042515)
36. Skorobogaty, A., White, R.J., Phillips, D.R., and Reiss, J.A. (1988). The 5¢-CA DNA-sequence preference of daunomycin. FEBS Letters 227, 103-106.
37. Spanswick, V.J., Craddock, C., Sekhar, M., Mahendra, P., Shankaranarayana, P., Hughes, R.G., Hochhauser, D., and Hartley, J.A. (2002). Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. Blood 100, 224-229. (Pubitemid 35177451)
38. Sunters, A., Springer, C.J., Bagshawe, K.D., Souhami, R.L., and Hartley J.A. (1992). The cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl) amino] benzoic acid. Biochem Pharmacol 44, 59-64.
39. Trist, H., and Phillips, D.R. (1989). In vitro transcription analysis of the role of flanking sequence on the DNA sequence specificity of Adriamycin. Nucleic Acid Res 17, 3673-3688. (Pubitemid 19153357)
40. Waring, M.J. (1981). DNA modification and cancer. Ann Rev Biochem 50, 159-192.
41. Zwelling, L.A., Bales, E., Altschuler, E., and Mayes, J. (1993). Circumvention of resistance by doxorubicin, but not by idarubicin, in a human leukemia cell line containing an intercalator-resistant form of topoisomerase II: evidence for a non-topoisomerase II-mediated mechanism of doxorubicin cytotoxicity. Biochem Pharmacol 45, 516-520. (Pubitemid 23042654)
42. Zwelling, L.A., Kerrigan, D., and Michaels, S. (1982). Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4¢-(9-acridinylamino) methanesulfon-m- anisidine. Cancer Res 42, 2687-2691. (Pubitemid 12085732)